ARCHIVES

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

August 7, 2009

Richard Pazdur’s Comments to ODAC

July 22, 2011

Columbia Formally Names As 21st Comprehensive Center

March 9, 1979

“Wild West” of Molecular Testing?: Caris Engaged in Aggressive Marketing, Improper Medicare Billing, Lawsuit Alleges

August 8, 2014

NIH Director Healy Resigned, To Return To Cleveland In June’ Kessler To Remain

March 5, 1993

CDC Offers Funds For 5-A-Day Program; CDC PA Available

May 14, 1999